NASDAQ:XNPT

(XNPT) (XNPT) Stock Price, News & Analysis

Notice: This company has been marked as potentially delisted and may not be actively trading.
Today's Range
$7.07
$7.07
50-Day Range
N/A
52-Week Range
$3.35
$7.86
Volume
N/A
Average Volume
1.22 million shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
XNPT stock logo

About (XNPT) Stock (NASDAQ:XNPT)

XenoPort, Inc. is a biopharmaceutical company. The Company is focused on commercializing HORIZANT (gabapentin enacarbil) Extended-Release Tablets in the United States. The Company's segment is the development and commercialization of product candidates for the treatment of neurological and other disorders. Its development-stage product candidates include XP23829, XP21279 and arbaclofen placarbil. HORIZANT has been approved by the United States Food and Drug Administration for the treatment of moderate-to-severe primary restless legs syndrome in adults and for the management of postherpetic neuralgia in adults. XP23829 is a fumaric acid ester compound and a prodrug of metabolite monomethyl fumarate being developed for the treatment for patients with moderate-to-severe chronic plaque-type psoriasis and/or patients with relapsing forms of multiple sclerosis. XP21279 is a Transported Prodrug of levodopa being developed for the treatment for patients with idiopathic Parkinson's disease.

XNPT Stock News Headlines

3 Biotech Stocks Under $10 Spiking Higher
Nvidia CEO Says It Will Be “the Next Revolution” Beyond AI
Nvidia’s CEO calls it the “next amazing revolution” … and even declared it “is going to be flat out of the biggest [revolution] ever.” Jeff Bezos, Bill Gates, and Mark Zuckerberg have invested billions in it.
Siddington
Nvidia CEO Says It Will Be “the Next Revolution” Beyond AI
Nvidia’s CEO calls it the “next amazing revolution” … and even declared it “is going to be flat out of the biggest [revolution] ever.” Jeff Bezos, Bill Gates, and Mark Zuckerberg have invested billions in it.
Five Dumbest Things on Wall Street: Feb. 26
See More Headlines
Receive XNPT Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for (XNPT) and its competitors with MarketBeat's FREE daily newsletter.

Industry, Sector and Symbol

Sector
N/A
Industry
N/A
Sub-Industry
Pharmaceuticals
Current Symbol
NASDAQ:XNPT
CUSIP
98411C10
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A

Miscellaneous

Free Float
N/A
Optionable
Not Optionable
Beta
N/A
Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

XNPT Stock Analysis - Frequently Asked Questions

What other stocks do shareholders of (XNPT) own?

Based on aggregate information from My MarketBeat watchlists, some companies that other (XNPT) investors own include Netflix (NFLX), Gilead Sciences (GILD), Intercept Pharmaceuticals (ICPT), Ionis Pharmaceuticals (IONS), Supernus Pharmaceuticals (SUPN), XOMA (XOMA), Allergan (AGN), Bausch Health Companies (BHC), Booking (BKNG) and

This page (NASDAQ:XNPT) was last updated on 4/29/2024 by MarketBeat.com Staff

From Our Partners